Incannex Healthcare (IXHL) Exchange Rate Effect (2023 - 2026)
Incannex Healthcare (IXHL) posted Exchange Rate Effect of $3.0 million for Q1 2026, up 878.35% sequentially from -$388000.0 in Q4 2025, and up 10685.71% YoY from N/an in Q1 2025.
Incannex Healthcare (IXHL) Exchange Rate Effect (2023 - 2026) Analysis & Trends
Incannex Healthcare has reported Exchange Rate Effect for 4 years, with the latest figure at $3.0 million in Q1 2026.
- Quarterly Exchange Rate Effect rose 10685.71% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 million (up 950.34% YoY) and the FY2025 annual result came in at $306000.0, up 318.57% from the prior year.
- Exchange Rate Effect climbed to $3.0 million in Q1 2026 per IXHL's latest filing, from -$388000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $3.0 million in Q1 2026 and troughed at -$905000.0 in Q1 2024.
- A 4-year average of $197818.2 and a median of $28000.0 in 2025 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2025 and 2026: Exchange Rate Effect slumped 792.86% in 2025, then surged 10685.71% in 2026.
- Over 4 years, Exchange Rate Effect stood at $26000.0 in 2023, then soared by 115.38% to $56000.0 in 2024, then plunged by 792.86% to -$388000.0 in 2025, then surged by 878.35% to $3.0 million in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $3.0 million, -$388000.0, and $269000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -5.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -7.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 39.87 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -3.30 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 9.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Incannex Healthcare | 44.39 Mn | 44.39 Mn | - | 3.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.02 Mn |
| Mar 31, 2026 | 3.02 Mn |
| Dec 31, 2025 | -388,000.00 |
| Dec 31, 2025 | -388,000.00 |
| Sep 30, 2025 | 269,000.00 |
| Sep 30, 2025 | 269,000.00 |
| Jun 30, 2025 | 208,000.00 |
| Jun 30, 2025 | 208,000.00 |
| Mar 31, 2025 | 28,000.00 |
| Mar 31, 2025 | 28,000.00 |
| Dec 31, 2024 | 56,000.00 |
| Dec 31, 2024 | 56,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 198,000.00 |
| Jun 30, 2024 | 198,000.00 |
| Mar 31, 2024 | -905,000.00 |
| Mar 31, 2024 | -905,000.00 |
| Jun 30, 2023 | 26,000.00 |
| Jun 30, 2023 | 26,000.00 |